Lexaria Bioscience (LEXX) Shares Outstanding (Diluted) (2010 - 2026)
Lexaria Bioscience's Shares Outstanding (Diluted) was 1.65 million in fiscal Q3 2026 (quarter ended May 31, 2026), up 35.6% from 1.22 million a year earlier and up 1.5% from the prior quarter.
Powered by 
Analysis
Lexaria Bioscience (LEXX) Shares Outstanding (Diluted) (2010 - 2026) Analysis & Trends
For FY2025 (ended Aug 31, 2025), Shares Outstanding (Diluted) at Lexaria Bioscience came in at 1.2 million, up 45.3% from FY2024.
- Shares Outstanding (Diluted) has now increased for three consecutive fiscal years, with a five-year compound annual growth rate of 97.3% (FY2020 to FY2025).
- In earlier fiscal years, Shares Outstanding (Diluted) was 825,598 in FY2024 (+87.2%), 440,938 in FY2023 (+997.5%), 40,176 in FY2022 (unchanged) and 40,176 in FY2021 (unchanged).
- The fiscal Q3 2026 figure marks the highest quarterly Shares Outstanding (Diluted) in data going back to fiscal Q4 2010.
- Compared with a year earlier, Shares Outstanding (Diluted) has increased for eight straight quarters, with growth averaging 51.9% over the last eight quarters.
- Across the past five years, year-over-year growth in Shares Outstanding (Diluted) ran from 0.0% in fiscal Q4 2021 to 997.5% in fiscal Q4 2023.
- Per Business Quant data, LEXX's Shares Outstanding (Diluted) in the three fiscal quarters before Q3 2026 was 1.63 million (Q2 2026), 1.43 million (Q1 2026) and 1.2 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 893.70 Mn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 2.44 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 1.56 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 544.00 Mn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Lexaria Bioscience | 3.26 Mn | -12.39 Mn | - | 1.65 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 1.65 Mn |
| Feb 28, 2026 | 1.63 Mn |
| Nov 30, 2025 | 1.43 Mn |
| Aug 31, 2025 | 1.20 Mn |
| May 31, 2025 | 1.22 Mn |
| Feb 28, 2025 | 1.17 Mn |
| Nov 30, 2024 | 1.11 Mn |
| Aug 31, 2024 | 825,598.00 |
| May 31, 2024 | 923,680.00 |
| Feb 29, 2024 | 717,676.00 |
| Nov 30, 2023 | 603,435.00 |
| Aug 31, 2023 | 440,938.00 |
| May 31, 2023 | 40,176.00 |
| Feb 28, 2023 | 40,176.00 |
| Nov 30, 2022 | 40,176.00 |
| Aug 31, 2022 | 40,176.00 |
| May 31, 2022 | 40,176.00 |
| Feb 28, 2022 | 40,176.00 |
| Nov 30, 2021 | 40,176.00 |
| Aug 31, 2021 | 40,176.00 |
API Access
Lexaria Bioscience Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=LEXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();